University of Thessaly (UTH)
Μελέτη της ανοσοτροποποιητικής δράσης του διχλωροξικού σε καλλιέργειες ανθρώπινων CD4+ T λεμφοκυττάρων
Abstract
dc:descriptionToday, kidney transplantation is considered to be the most widespread treatment for end-stage renal failure. However, the development of novel, more effective and safer immunosuppressants is considered essential given the serious complications of renal transplanted patients.Recent research has been focused on investigating substances that interfere with the metabolism of allogeneic CD4+ T cells, inhibit aerobic glycolysis and direct their differentiation to Tregs instead of Teffs. The latter are the main mediators of rejection of allogenic grafts whereas, on the contrary, Tregs have been shown to contribute to graft tolerance. In this context, dichloroacetic acid (DCA) is a drug that inhibits aerobic glycolysis and is already used in the treatment of hereditary lactic acidosis without side effects. The aim of this PhD dissertation was to investigate the potential immunomodulatory effect of DCA focusing on the metabolism of allogeneic CD4+ T-lymphocytes and their differentiation into effector or regulatory subsets.In this context, two-way mixed lymphocyte reaction (MLR) was used as a model of alloreactivity. Initially, in order to study the effect of DCA on the metabolic pathway of aerobic glycolysis, both glucose consumption and lactic acid production were measured in the supernatant of cell cultures. Moreover, the effect of the drug on cell proliferation was assessed with 5-bromo-2'-deoxyuridine (BrdU) immunostaining. In addition to this, human alloreactive CD4+ T-cells of each MLR were isolated using negative magnetic separation and the effect of DCA on the relative protein expression of: (a) transporters and enzymes involved in glycolysis; (b) cleaved caspase-3, marker of cellular apoptosis; and c) transcriptional markers that characterize the differentiation of CD4+ T lymphocytes to effector or regulatory subsets, was assessed by Western blotting.The results of our experiments showed that in MLRs, DCA reduced glucose consumption and aerobic glycolysis while having a negligible effect on cell proliferation. In addition, with respect to human alloreactive CD4+ T-lymphocytes isolated from MLRs, DCA:a) reduced the protein expression of the glucose receptor GLUT1, hexokinase II, lactate dehydrogenase A and phosphorylated pyruvate dehydrogenase, while increasing total pyruvate dehydrogenase.b) increased the protein expression levels of cleaved (activated) caspase-3c) increased the protein expression levels of FoxP3, a transcriptional factor and lineage marker of CD4+ Tregs, while reducing expression of RORγt, GATA-3 and T-bet transcription factors and markers of differentiation of CD4+ T-lymphocytes to effector Th17, Th2 and Th1 subspecies, respectively.Summarizing, in alloreactive CD4+ T lymphocytes, DCA inhibits aerobic glycolysis, induces cell apoptosis and favors differentiation into Tregs. The above data, couple with the fact that DCA is already used in clinical practice, rendering it a promising immunosuppressive drug in the field of solid organ transplantation.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sounidaki, Maria
- Σουνιδάκη, Μαρία
Subjects
dc:subject × 12Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46010